These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36797128)

  • 41. Does sites of recurrence impact survival in secondary cytoreduction surgery for recurrent epithelial ovarian cancer?
    Kumar S; Srinivasan A; Phillips A; Madhupriya R; Pascoe J; Nevin J; Elattar A; Balega J; Cummins C; Sundar S; Kehoe ST; Singh K
    J Obstet Gynaecol; 2020 Aug; 40(6):849-855. PubMed ID: 31933417
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Surgical management of ovarian cancer: Trends in clinical practice].
    Querleu D; Meurette J; Daraï E; Morice P; Planchamp F
    Bull Cancer; 2016 Nov; 103(11):935-940. PubMed ID: 27769513
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Epithelial ovarian cancer and fertility preservation: Article drafted from the French Guidelines in oncology entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY under the aegis of CNGOF and endorsed by INCa].
    Uzan C; Courbiere B; Chabbert-Buffet N
    Gynecol Obstet Fertil Senol; 2019 Feb; 47(2):180-186. PubMed ID: 30704956
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Overall Survival Following Neoadjuvant Chemotherapy vs Primary Cytoreductive Surgery in Women With Epithelial Ovarian Cancer: Analysis of the National Cancer Database.
    Rauh-Hain JA; Melamed A; Wright A; Gockley A; Clemmer JT; Schorge JO; Del Carmen MG; Keating NL
    JAMA Oncol; 2017 Jan; 3(1):76-82. PubMed ID: 27892998
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of residual disease at interval debulking surgery on platinum resistance and patterns of recurrence for advanced-stage ovarian cancer.
    Greer A; Gockley A; Manning-Geist B; Melamed A; Sisodia RC; Berkowitz R; Horowitz N; Del Carmen M; Growdon WB; Worley M
    Int J Gynecol Cancer; 2021 Oct; 31(10):1341-1347. PubMed ID: 34429355
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Using an evidence-based triage algorithm to reduce 90-day mortality after primary debulking surgery for advanced epithelial ovarian cancer.
    Narasimhulu DM; Kumar A; Weaver AL; McGree ME; Langstraat CL; Cliby WA
    Gynecol Oncol; 2019 Oct; 155(1):58-62. PubMed ID: 31402165
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Malignant epithelial ovarian cancer: Role of intra peritoneal chemotherapy and hyperthermic intra peritoneal chemotherapy (HIPEC): Article drafted from the French Guidelines in oncology entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY under the aegis of CNGOF and endorsed by INCa].
    Bakrin N; Gladieff L
    Gynecol Obstet Fertil Senol; 2019 Feb; 47(2):214-221. PubMed ID: 30712963
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adherence to European ovarian cancer guidelines and impact on survival: a French multicenter study (FRANCOGYN).
    Jochum F; De Rozario T; Lecointre L; Faller E; Boisrame T; Dabi Y; Lavoué V; Coutant C; Touboul C; Bolze PA; Bricou A; Canlorbe G; Collinet P; Huchon C; Bendifallah S; Ouldamer L; Mezzadri M; Querleu D; Akladios C
    Int J Gynecol Cancer; 2021 Nov; 31(11):1443-1452. PubMed ID: 34607855
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Fertility].
    Raad J; Rolland L; Grynberg M; Courbiere B; Mathieu d'Argent E
    Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):330-336. PubMed ID: 32004782
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chemotherapy alone for patients 75 years and older with epithelial ovarian cancer-is interval cytoreductive surgery still needed?
    Klein DA; Mann AK; Freeman AH; Liao CI; Kapp DS; Chan JK
    Am J Obstet Gynecol; 2020 Feb; 222(2):170.e1-170.e11. PubMed ID: 31421122
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Surgical outcomes and national comprehensive cancer network compliance in advanced ovarian cancer surgery in a low volume military treatment facility.
    Phippen NT; Barnett JC; Lowery WJ; Miller CR; Leath CA
    Gynecol Oncol; 2013 Oct; 131(1):158-62. PubMed ID: 23872110
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Follow-up of patients treated for an epithelial ovarian cancer, place of hormone replacement therapy and of contraception: Article drafted from the French Guidelines in oncology entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY under the aegis of CNGOF and endorsed by INCa].
    Sénéchal C; Akladios C; Bendifallah S; Ouldamer L; Lecuru F; Rousset-Jablonski C
    Gynecol Obstet Fertil Senol; 2019 Feb; 47(2):250-262. PubMed ID: 30685388
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Preoperative serum CA-125 level as a predictor for the extent of cytoreduction in patients with advanced stage epithelial ovarian cancer.
    Merlo S; Besic N; Drmota E; Kovacevic N
    Radiol Oncol; 2021 Aug; 55(3):341-346. PubMed ID: 33675192
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of subcutaneous negative pressure drains on surgical wound healing in ovarian cancer.
    Chung YS; Lee JY; Nam EJ; Kim S; Kim SW; Kim YT
    Int J Gynecol Cancer; 2021 Feb; 31(2):245-250. PubMed ID: 32675054
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of major postoperative complications on recurrence and long-term survival after cytoreductive surgery for ovarian cancer.
    Angeles MA; Hernández A; Pérez-Benavente A; Cabarrou B; Spagnolo E; Rychlik A; Daboussi A; Migliorelli F; Bétrian S; Ferron G; Gil-Moreno A; Guyon F; Martinez A
    Gynecol Oncol; 2022 Jul; 166(1):8-17. PubMed ID: 35568582
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Surgical management of patients with advanced ovarian cancer: Results of a French National Survey.
    Gauci PA; Deluche E; Azais H; Zaccarini F; Guani B; Balaya V; Kerbage Y; Jochum F; Sanson C; Guyon F; Akladios C; Bendifallah S; Dabi Y
    J Gynecol Obstet Hum Reprod; 2022 Nov; 51(9):102463. PubMed ID: 36031186
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Initial management of epithelial ovarian cancer. Methods and organization.Article written on the basis of French joint guidelines of CNGOF, FRANCOGYN, SFOG, GINECO-ARCAGY and INCa].
    Huchon C; Lavoué V; Darai E
    Gynecol Obstet Fertil Senol; 2019 Feb; 47(2):95-99. PubMed ID: 30683628
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Racial disparities in the treatment of advanced epithelial ovarian cancer.
    Howell EA; Egorova N; Hayes MP; Wisnivesky J; Franco R; Bickell N
    Obstet Gynecol; 2013 Nov; 122(5):1025-1032. PubMed ID: 24104782
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term post-recurrence survival outcomes in young women receiving fertility-sparing surgery for epithelial ovarian cancer.
    Shigeyama M; Yoshihara M; Kitami K; Mogi K; Uno K; Iyoshi S; Tano S; Yoshikawa N; Kajiyama H
    Eur J Obstet Gynecol Reprod Biol; 2021 Dec; 267():221-225. PubMed ID: 34826670
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Centralisation of epithelial ovarian cancer surgery: results on survival from a peripheral teaching hospital.
    van Vliet MM; Schreuder HW; Pasker-de Jong PC; Duk MJ
    Eur J Obstet Gynecol Reprod Biol; 2015 Sep; 192():72-8. PubMed ID: 26177496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.